Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

109
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
109
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

148
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
148
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

252
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
252
Regression Toward the Mean01:52

Regression Toward the Mean

6.6K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.6K
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

605
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
605
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

140
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
140

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No evidence that nonincentivized behavioral interventions effectively mitigate climate change after adjusting for publication bias.

PNAS nexus·2026
Same author

Robust Bayesian multilevel meta-analysis: Adjusting for publication bias in the presence of dependent effect sizes.

Behavior research methods·2026
Same author

Investigating the reproducibility of the social and behavioural sciences.

Nature·2026
Same author

Investigating the replicability of the social and behavioural sciences.

Nature·2026
Same author

Investigating the analytical robustness of the social and behavioural sciences.

Nature·2026
Same author

Incorporation bias in clinical prediction models for epilepsy.

Epilepsia open·2026
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Oct 15, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

804

Bayesian model-averaged meta-analysis in medicine.

František Bartoš1, Quentin F Gronau1, Bram Timmers1

  • 1Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands.

Statistics in Medicine
|October 27, 2021
PubMed
Summary
This summary is machine-generated.

This study introduces a Bayesian model-averaged meta-analysis to assess treatment effectiveness and heterogeneity. The model assuming both treatment effects and heterogeneity generally performed best, offering insights for prior distributions in medical research.

Keywords:
Bayes factorempirical prior distributionevidence

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.5K

Related Experiment Videos

Last Updated: Oct 15, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

804
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.5K

Area of Science:

  • Biostatistics
  • Medical Research Methodology
  • Evidence Synthesis

Background:

  • Meta-analysis is crucial for synthesizing evidence from multiple studies.
  • Quantifying treatment effectiveness and across-study heterogeneity is essential for reliable conclusions.
  • Bayesian model averaging (BMA) offers a robust framework for meta-analysis.

Purpose of the Study:

  • To develop and evaluate a Bayesian model-averaged meta-analysis for standardized mean differences.
  • To quantify evidence for treatment effectiveness and across-study heterogeneity.
  • To propose empirical prior distributions for BMA meta-analyses.

Main Methods:

  • Developed four competing models based on assumptions of treatment effect and heterogeneity.
  • Utilized 50% of the Cochrane Database to specify prior distributions.
  • Assessed model and prior predictive performance using the remaining 50% of the database.
  • Employed Bayesian model averaging (BMA) for meta-analysis.

Main Results:

  • The model incorporating both treatment effect and heterogeneity demonstrated superior predictive performance.
  • Predictive adequacy was consistent across different prior distributions.
  • Proposed specific empirical prior distributions for general use and 46 medical subdisciplines.

Conclusions:

  • Bayesian model-averaged meta-analysis provides a robust method for evaluating treatment effectiveness and heterogeneity.
  • The proposed empirical prior distributions can enhance the application of BMA in medical research.
  • The study offers practical guidance for conducting BMA meta-analyses using open-source software.